Á¦2Â÷ ¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò Çмú´ëȸ : 2023-12-16
±³À°ÀÏÀÚ : 2023-12-16
±³À°Àå¼Ò : ¿¬¼¼¾Ïº´¿ø ¼¾Ï°´ç
±³À°ÁÖÁ¦ : Á¦2Â÷ ¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò Çмú´ëȸ
ÁÖÃÖ±â°ü : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò
´ã´çÀÚ : ¾î°æÁø
¿¬¶ôó : 02-2228-2232
À̸ÞÀÏ : ob@yuhs.ac
±³À°Á¾·ù : ±âŸ
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12¿ù 16ÀÏ ¼¾Ï°´ç 13:00~13:10 Ãà»ç ¹× °³È¸»ç µî ±è»ó¿î(¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 13:10~13:25 (ÃÊ·Ï)Fine particulate matter (PM2.5) exposure suppresses the decidualization and implantation of Endometrial stromal cell and trophoblast through PROK1/PROK1R regulation Á¤À±Áö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 13:25~13:40 (ÃÊ·Ï)The Effect of Microplastics on the Human Pregnancy at the Maternal Fetal Interface ÇãÇý¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 13:40~13:55 (ÃÊ·Ï)Non-invasive fetal electroencephalography (EEG) Emily Lee(¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 13:55~14:20 Fetal US and Artificial Intelligence ±ÇÀÚ¿µ(¿¬¼¼ÀÇ´ë)
Åä·Ð 12¿ù 16ÀÏ ¼¾Ï°´ç 14:20~14:30 Discussion (¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 12¿ù 16ÀÏ ¼¾Ï°´ç 14:30~14:40 Coffee Break (¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 14:40~14:50 (ÃÊ·Ï)Extracellular vesicle hsa-miR-200a-3p and hsa-miR-29a-3p derived from in vitro endometriosis model reduce mitochondrial apoptosis by the autocrine effect ¹èÁö¹Î(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 14:50~15:00 (ÃÊ·Ï)Particulate Matter Exposures Induce Adverse Effects on Endometrial cells via Aberrant Inflammatory Pathways in vitro and in vivo ½ÅÀ¯¸®(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 15:00~15:10 (ÃÊ·Ï)Transcriptomic patterns in early-secretory and mid-secretory endometrium in a natural menstrual cycle immediately before in vitro fertilization and embryo transfer ¹ÚÇý¹Î(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 15:10~15:20 (ÃÊ·Ï)Catheter-Directed Sclerotherapy for Endometrioma; studies over the years and future prospectives ÀÌÀç°æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 15:20~15:30 (ÃÊ·Ï)Hormone replacement therapy and Breast cancer incidence in Korean women ÃÖÀº¾Æ(¿¬¼¼ÀÇ´ë)
Åä·Ð 12¿ù 16ÀÏ ¼¾Ï°´ç 15:30~15:40 Discussion (¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 12¿ù 16ÀÏ ¼¾Ï°´ç 15:40~15:50 Coffee Break (¿¬¼¼ÀÇ´ë)
±âŸ 12¿ù 16ÀÏ ¼¾Ï°´ç 15:50~16:40 Æ÷½ºÅÍ ¼¼¼Ç (¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 16:40~16:50 (ÃÊ·Ï)Immune Characteristics of Tumor-infiltrating Lymphocytes in endometrial cancer; molecular classification ±èÁ¤Ã¶(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 16:50~17:00 (ÃÊ·Ï)Is Presumed Clinical Stage I Endometrial Cancer in PET-CT and MRI Truly Stage I in Surgical Staging? ¼±±âÀº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 17:00~17:10 (ÃÊ·Ï)The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation ÀÌ¿µÁÖ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 17:10~17:20 (ÃÊ·Ï)Clinical features of cancers diagnosed in patients with Lynch syndrome-associated gene germline mutations ÀÌÁöÀº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 16ÀÏ ¼¾Ï°´ç 17:20~17:30 (ÃÊ·Ï)A comparison of clinical outcomes between Manchester Fothergill and vaginal hysterectomy in the treatment of uterine prolapse Á¶Á¤¼ö(¿¬¼¼ÀÇ´ë)
Åä·Ð 12¿ù 16ÀÏ ¼¾Ï°´ç 17:30~17:40 Discussion (¿¬¼¼ÀÇ´ë)
±âŸ 12¿ù 16ÀÏ ¼¾Ï°´ç 17:40~18:00 ½Ã»ó½Ä ¹× »çÁøÃÔ¿µ, Æóȸ»ç Á¶½ÃÇö(¿¬¼¼ÀÇ´ë)